Source: BioPortfolio

Confluence Life Sciences: Confluence Life Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17102017 Prices from USD $250

SummaryConfluence Life Sciences Inc Confluence is a medicines developing company that discovers medicine for treatment of cancer and autoimmune and inflammatory. The company designs and develops kinase inhibitors focusing on the enzymes that regulate the g...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Walter Smith's photo - CEO of Confluence Life Sciences

CEO

Walter Smith

CEO Approval Rating

71/100

Read more